Literature DB >> 31942606

Current genetic landscape in common variable immune deficiency.

Hassan Abolhassani1,2, Lennart Hammarström1, Charlotte Cunningham-Rundles3,4.   

Abstract

Using whole-exome sequencing to examine the genetic causes of immune deficiency in 235 common variable immunodeficiency (CVID) patients seen in the United States (Mount Sinai, New York), 128 patients from Sweden, and 208 from Iran revealed 68 known disease-causing genes underlying this heterogeneous immune defect. The patients at the time of study ranged from 4 to 90 years of age. Overall, 31%, 36%, and 54% of the patients in the US, Swedish, or Iranian cohorts had mutations. The multiplicity of genes identified in the 571 subjects reflects the complex requirements of B-cell antigen signaling, activation, survival, migration, maturation, and maintenance of antibody-secreting memory B-cell populations to the plasma cell stage. For the US and Swedish cohorts, CVID subjects with noninfectious complications, lymphoid infiltrations, inflamatory conditions, or autoimmunity were somewhat more likely to have an identifiable gene, but in both cohorts, numerous subjects with these medical conditions had no potential gene that could be assigned. Specific clinical patterns of illnesses were also not linked to any given gene defect as there was considerable overlap in clinical presentations. These observations led to a new perspective on the complexity of the immunologic phenotype found in CVID syndrome.
© 2020 by The American Society of Hematology.

Entities:  

Mesh:

Year:  2020        PMID: 31942606      PMCID: PMC7046605          DOI: 10.1182/blood.2019000929

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  49 in total

1.  The mutation significance cutoff: gene-level thresholds for variant predictions.

Authors:  Yuval Itan; Lei Shang; Bertrand Boisson; Michael J Ciancanelli; Janet G Markle; Ruben Martinez-Barricarte; Eric Scott; Ishaan Shah; Peter D Stenson; Joseph Gleeson; David N Cooper; Lluis Quintana-Murci; Shen-Ying Zhang; Laurent Abel; Jean-Laurent Casanova
Journal:  Nat Methods       Date:  2016-02       Impact factor: 28.547

2.  Mutations in TNFRSF13B encoding TACI are associated with common variable immunodeficiency in humans.

Authors:  U Salzer; H M Chapel; A D B Webster; Q Pan-Hammarström; A Schmitt-Graeff; M Schlesier; H H Peter; J K Rockstroh; P Schneider; A A Schäffer; L Hammarström; B Grimbacher
Journal:  Nat Genet       Date:  2005-07-10       Impact factor: 38.330

Review 3.  Primary immunodeficiencies. Report of a World Health Organization Committee.

Authors:  H Fudenberg; R A Good; H C Goodman; W Hitzig; H G Kunkel; I M Roitt; F S Rosen; D S Rowe; M Seligmann; J R Soothill
Journal:  Pediatrics       Date:  1971-05       Impact factor: 7.124

Review 4.  The Ying and Yang of STAT3 in Human Disease.

Authors:  Tiphanie P Vogel; Joshua D Milner; Megan A Cooper
Journal:  J Clin Immunol       Date:  2015-08-18       Impact factor: 8.317

5.  The extended phenotype of LPS-responsive beige-like anchor protein (LRBA) deficiency.

Authors:  Laura Gámez-Díaz; Dietrich August; Polina Stepensky; Shoshana Revel-Vilk; Markus G Seidel; Mitsuiki Noriko; Tomohiro Morio; Austen J J Worth; Jacob Blessing; Frank Van de Veerdonk; Tobias Feuchtinger; Maria Kanariou; Annette Schmitt-Graeff; Sophie Jung; Suranjith Seneviratne; Siobhan Burns; Bernd H Belohradsky; Nima Rezaei; Shahrzad Bakhtiar; Carsten Speckmann; Michael Jordan; Bodo Grimbacher
Journal:  J Allergy Clin Immunol       Date:  2016-01       Impact factor: 10.793

Review 6.  Immunodeficiency, centromeric region instability, facial anomalies syndrome (ICF).

Authors:  Melanie Ehrlich; Kelly Jackson; Corry Weemaes
Journal:  Orphanet J Rare Dis       Date:  2006-03-01       Impact factor: 4.123

7.  Association of CLEC16A with human common variable immunodeficiency disorder and role in murine B cells.

Authors:  Jin Li; Silje F Jørgensen; S Melkorka Maggadottir; Marina Bakay; Klaus Warnatz; Joseph Glessner; Rahul Pandey; Ulrich Salzer; Reinhold E Schmidt; Elena Perez; Elena Resnick; Sigune Goldacker; Mary Buchta; Torsten Witte; Leonid Padyukov; Vibeke Videm; Trine Folseraas; Faranaz Atschekzei; James T Elder; Rajan P Nair; Juliane Winkelmann; Christian Gieger; Markus M Nöthen; Carsten Büning; Stephan Brand; Kathleen E Sullivan; Jordan S Orange; Børre Fevang; Stefan Schreiber; Wolfgang Lieb; Pål Aukrust; Helen Chapel; Charlotte Cunningham-Rundles; Andre Franke; Tom H Karlsen; Bodo Grimbacher; Hakon Hakonarson; Lennart Hammarström; Eva Ellinghaus
Journal:  Nat Commun       Date:  2015-04-20       Impact factor: 14.919

8.  Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Authors:  Sue Richards; Nazneen Aziz; Sherri Bale; David Bick; Soma Das; Julie Gastier-Foster; Wayne W Grody; Madhuri Hegde; Elaine Lyon; Elaine Spector; Karl Voelkerding; Heidi L Rehm
Journal:  Genet Med       Date:  2015-03-05       Impact factor: 8.822

9.  Autosomal dominant immune dysregulation syndrome in humans with CTLA4 mutations.

Authors:  Desirée Schubert; Claudia Bode; Rupert Kenefeck; Tie Zheng Hou; Lucy S K Walker; David M Sansom; Bodo Grimbacher; James B Wing; Alan Kennedy; Alla Bulashevska; Britt-Sabina Petersen; Alejandro A Schäffer; Björn A Grüning; Susanne Unger; Natalie Frede; Ulrich Baumann; Torsten Witte; Reinhold E Schmidt; Gregor Dueckers; Tim Niehues; Suranjith Seneviratne; Maria Kanariou; Carsten Speckmann; Stephan Ehl; Anne Rensing-Ehl; Klaus Warnatz; Mirzokhid Rakhmanov; Robert Thimme; Peter Hasselblatt; Florian Emmerich; Toni Cathomen; Rolf Backofen; Paul Fisch; Maximilian Seidl; Annette May; Annette Schmitt-Graeff; Shinji Ikemizu; Ulrich Salzer; Andre Franke; Shimon Sakaguchi
Journal:  Nat Med       Date:  2014-10-20       Impact factor: 53.440

10.  Assessing the Functional Relevance of Variants in the IKAROS Family Zinc Finger Protein 1 (IKZF1) in a Cohort of Patients With Primary Immunodeficiency.

Authors:  Zoya Eskandarian; Manfred Fliegauf; Alla Bulashevska; Michele Proietti; Rosie Hague; Cristian Roberto Smulski; Desirée Schubert; Klaus Warnatz; Bodo Grimbacher
Journal:  Front Immunol       Date:  2019-04-16       Impact factor: 7.561

View more
  35 in total

1.  Comprehensive Assessment of Skin Disorders in Patients with Common Variable Immunodeficiency (CVID).

Authors:  Ali Zarezadeh Mehrabadi; Nazanin Aghamohamadi; Hassan Abolhassani; Asghar Aghamohammadi; Nima Rezaei; Reza Yazdani
Journal:  J Clin Immunol       Date:  2022-01-27       Impact factor: 8.317

2.  Lymphoma as an Exclusion Criteria for CVID Diagnosis Revisited.

Authors:  Vincent Allain; Virginie Grandin; Véronique Meignin; Rémi Bertinchamp; David Boutboul; Claire Fieschi; Lionel Galicier; Laurence Gérard; Marion Malphettes; Jacinta Bustamante; Mathieu Fusaro; Nathalie Lambert; Jérémie Rosain; Christelle Lenoir; Sven Kracker; Frédéric Rieux-Laucat; Sylvain Latour; Jean-Pierre de Villartay; Capucine Picard; Eric Oksenhendler
Journal:  J Clin Immunol       Date:  2022-09-26       Impact factor: 8.542

Review 3.  Autoimmune Cytopenias in Common Variable Immunodeficiency Are a Diagnostic and Therapeutic Conundrum: An Update.

Authors:  Sanchi Chawla; Prabal Barman; Rahul Tyagi; Ankur Kumar Jindal; Saniya Sharma; Amit Rawat; Surjit Singh
Journal:  Front Immunol       Date:  2022-06-20       Impact factor: 8.786

4.  The ABACHAI clinical trial protocol: Safety and efficacy of abatacept (s.c.) in patients with CTLA-4 insufficiency or LRBA deficiency: A non controlled phase 2 clinical trial.

Authors:  Máté Krausz; Annette Uhlmann; Ina Caroline Rump; Gabriele Ihorst; Sigune Goldacker; Georgios Sogkas; Sara Posadas-Cantera; Reinhold Schmidt; Manuel Feißt; Laia Alsina; Ingunn Dybedal; Mike Recher; Klaus Warnatz; Bodo Grimbacher
Journal:  Contemp Clin Trials Commun       Date:  2022-09-24

Review 5.  Diagnostic Modalities in Primary Immunodeficiency.

Authors:  Loveita S Raymond; Jennifer Leiding; Lisa R Forbes-Satter
Journal:  Clin Rev Allergy Immunol       Date:  2022-03-15       Impact factor: 10.817

6.  A Pathogenic Missense Variant in NFKB1 Causes Common Variable Immunodeficiency Due to Detrimental Protein Damage.

Authors:  Manfred Fliegauf; Renate Krüger; Sophie Steiner; Leif Gunnar Hanitsch; Sarah Büchel; Volker Wahn; Horst von Bernuth; Bodo Grimbacher
Journal:  Front Immunol       Date:  2021-04-27       Impact factor: 7.561

7.  Bronchiectasis is associated with delayed diagnosis and adverse outcomes in the New Zealand Common Variable Immunodeficiency Disorders cohort study.

Authors:  R Ameratunga; A Jordan; A Cavadino; S Ameratunga; T Hills; R Steele; M Hurst; B McGettigan; I Chua; M Brewerton; N Kennedy; W Koopmans; Y Ahn; R Barker; C Allan; P Storey; C Slade; A Baker; L Huang; S-T Woon
Journal:  Clin Exp Immunol       Date:  2021-04-12       Impact factor: 5.732

8.  Lymphoid malignancy in common variable immunodeficiency in a single-center cohort.

Authors:  Tukisa Smith; Charlotte Cunningham-Rundles
Journal:  Eur J Haematol       Date:  2021-08-06       Impact factor: 2.997

9.  Transient hypogammaglobulinemia of infancy may be associated with reduced switched memory B cells and del (16) (p11.2p12).

Authors:  Tsuyoshi Ito; Shotaro Iwamoto; Masahiro Hirayama; Yasuharu Yamada; Eiichi Azuma
Journal:  Clin Case Rep       Date:  2021-06-22

10.  A CVID-associated variant in the ciliogenesis protein CCDC28B disrupts immune synapse assembly.

Authors:  Nagaja Capitani; Anna Onnis; Francesca Finetti; Chiara Cassioli; Alessandro Plebani; Jlenia Brunetti; Arianna Troilo; Sofia D'Elios; Manuela Baronio; Luisa Gazzurelli; Chiara Della Bella; Daniel D Billadeau; Mario Milco D'Elios; Vassilios Lougaris; Cosima T Baldari
Journal:  Cell Death Differ       Date:  2021-07-22       Impact factor: 12.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.